Legend Biotech (LEGN) Retained Earnings (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Retained Earnings data on file, last reported at $967.6 million in Q1 2026.

• Quarterly Retained Earnings fell 4.91% year-over-year to $967.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $967.6 million (down 4.91% YoY) and the FY2025 annual result came in at $1.0 billion, down 3.7% from the prior year.
• Retained Earnings retreated to $967.6 million in Q1 2026, from $1.0 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.4 billion in Q2 2023 to a low of $562.6 million in Q2 2022.
• A 5-year average of $1.0 billion and a median of $1.0 billion in 2025 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings soared 381546.94% — and 2024, when it dropped 17.63%.
• Tracing LEGN's Retained Earnings over 5 years: stood at $744.0 million in 2022, then jumped by 68.19% to $1.3 billion in 2023, then fell by 16.85% to $1.0 billion in 2024, then slipped by 3.7% to $1.0 billion in 2025, then decreased by 3.43% to $967.6 million in 2026.
• The last three Retained Earnings figures came in at $967.6 million (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.